文献速递类风湿关节炎

类风湿关节炎最早阶段血清氧脂素谱分析

Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2021-01-29

该研究纳入60例早期RA、11例临床可疑关节痛(CSA)和28名健康对照,用液相色谱串联质谱检测血清中75种氧脂素。结果显示三组间14种氧脂素表达模式不同,网络分析和聚类分析可区分组别并与疾病严重程度及6、12个月缓解率低相关,提示氧脂素网络在RA最早阶段存在差异并可能与疾病进展和治疗反应相关。

要点

  • 早期RA、CSA与健康对照的血清氧脂素表达模式和网络结构存在差异。
  • 氧脂素聚类使用在组间分布不同(P=0.003),并与疾病严重程度及初始未治疗RA患者6和12个月低缓解率相关。
  • 通路富集分析提示CSA中花生四烯酸通路相关,早期RA中脂氧合酶通路相关。

核心结论

  • 氧脂素网络在RA最早阶段的不同时期存在差异,可能有助于阐明与疾病进展、临床异质性和治疗反应相关的通路。

研究设计与样本

  • 研究纳入60例早期RA(符合ACR/EULAR 2010标准)、11例临床可疑关节痛(CSA)和28名健康对照,采集起病时血清。
  • 早期RA组中50例招募时未使用DMARD或糖皮质激素的患者,在接受传统合成DMARD后前瞻性随访至6和12个月。
  • 采用液相色谱串联质谱检测血清中75种氧脂素,主要来源于花生四烯酸、二十碳五烯酸和亚油酸。

主要发现

  • 单变量分析显示14种氧脂素在RA、CSA和健康对照三组间表达模式存在差异,各组呈现不同轨迹。
  • 网络分析显示RA患者氧脂素呈强分组模式,而CSA个体中氧脂素网络模糊且具有更高的度和紧密度。
  • 偏最小二乘判别分析得到22种氧脂素的变量重要投影值>1,可识别2个聚类。
  • 聚类使用在组间分布不同(P=0.003),并与疾病严重程度及初始未治疗RA患者6和12个月低缓解率相关。
  • 通路富集分析显示组间前体和通路不同,突出CSA中花生四烯酸通路和早期RA中脂氧合酶通路的相关性。

关键数值与推荐

  • 早期RA诊断依据ACR/EULAR 2010标准。
  • 22种氧脂素的变量重要投影值>1。
  • 聚类使用在组间差异的P=0.003。

临床怎么用

  • 血清氧脂素谱可能作为早期RA疾病分层和预后评估的潜在生物标志物,但尚需进一步验证。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Eicosanoids modulate inflammation via complex networks involving different pathways and downstream mediators, including oxylipins. Although altered eicosanoids are linked to rheumatoid arthritis (RA), suggesting that metabolization is enhanced, the role of oxylipins in disease stratification remains unexplored. This study was undertaken to characterize oxylipin networks during the earliest stages of RA and evaluate their associations with clinical features and treatment outcomes. METHODS: In total, 60 patients with early RA (according to the American College of Rheumatology/European League Against Rheumatism 2010 criteria), 11 individuals with clinically suspect arthralgia (CSA), and 28 healthy control subjects were recruited. Serum samples were collected at the time of onset. In the early RA group, 50 patients who had not been exposed to disease-modifying antirheumatic drug (DMARD) or glucocorticoid treatment at the time of recruitment were prospectively followed up at 6 and 12 months after having received conventional synthetic DMARDs. A total of 75 oxylipins, mostly derived from arachidonic, eicosapentanoic, and linoleic acids, were identified in the serum by liquid chromatography tandem mass spectrometry. RESULTS: Univariate analyses demonstrated differences in expression patterns of 14 oxylipins across the RA, CSA, and healthy control groups, with each exhibiting a different trajectory. Network analyses revealed a strong grouping pattern of oxylipins in RA patients, whereas in individuals with CSA, a fuzzy network of oxylipins with higher degree and closeness was found. Partial least-squares discriminant analyses yielded variable important projection scores of >1 for 22 oxylipins, which allowed the identification of 2 clusters. Cluster usage differed among the groups (P = 0.003), and showed associations with disease severity and low rates of remission at 6 and 12 months in RA patients who were initially treatment-naive. Pathway enrichment analyses revealed different precursors and pathways between the groups, highlighting the relevance of the arachidonic acid pathway in individuals with CSA and the lipooxygenase pathway in patients with early RA. In applying distinct oxylipin signatures, subsets of seropositive and seronegative RA could be identified. CONCLUSION: Oxylipin networks differ across stages during the earliest phases of RA. These distinct oxylipin networks could potentially elucidate pathways with clinical relevance for disease progression, clinical heterogeneity, and treatment response.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Carrio J, Coras R, Alperi-López M, et al. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis. Arthritis Rheumatol. 2021. PMID: 33001576. doi:10.1002/art.41537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。